🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Metastatic Colorectal Cancer (mCRC)

AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond NCT06678919n/a7 sites📍 Linz📍 Linz📍 Rankweil Arbeitsgemeinschaft medikamentoese Tumortherapie A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC NCT03303495Phase 31 site📍 Guangzhou Sun Yat-sen University · Tests: Bevacizumab, CPT-11, 5-FU Bolus, 5-FU Infusion, l-LV (dl-LV) A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α SrRNA in Treating Metastatic CRC Patients NCT06621173EARLY Phase 11 site📍 Shanghai Shanghai Changzheng Hospital · Tests: HNF4α srRNA Exosome-derived Extrahepatic Metastasis Detection By Liquid Biopsy In Colorectal Cancer Liver Metastases NCT07224724n/a1 site📍 Duarte City of Hope Medical Center · Tests: EXELION A Study of ASP1002 in Adults for Treatment of Solid Tumors NCT05719558Phase 115 sites📍 New Haven📍 Plainville📍 Gainesville Astellas Pharma Global Development, Inc. · Tests: ASP1002, Bevacizumab, Oxaliplatin, Leucovorin, Fluorouracil Evaluation of a Diagnostic Test to Identify the Best Drugs for Treatment of Metastatic Colorectal Cancer NCT07171554NA1 site📍 Lørenskog Oncosyne AS · Tests: µCAN drug screen test, Standard-of-Care Therapy Streamlining Radioembolization for CCC and Metastatic Liver Cancer NCT07043387n/a4 sites📍 Goyang-si📍 Seoul📍 Seoul Seoul National University Hospital A Clinical Study of Arfolitixorin in Patients With mCRC NCT06922383Phase 1, Phase 23 sites📍 Berlin📍 Essen📍 München Isofol Medical AB · Tests: Arfolitixorin, Leucovorin Randomized Controlled Trial of the Effects of Combined Resistance and AerobiC Exercise on Health-related Quality of Life in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer (REACH) NCT06938971NA4 sites📍 Copenhagen📍 Herlev📍 Hillerød Copenhagen University Hospital, Rigshospitalet · Tests: Exercise training A Study to Monitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South Korea NCT07035886n/a1 site📍 Seoul Takeda · Tests: No intervention DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit NCT06645236NA1 site📍 Manchester QIAGEN Gaithersburg, Inc · Tests: therascreen® KRAS RGQ PCR Kit ctDNA Monitoring in Patients With HCC and mCRC NCT07001085NA1 site📍 Warsaw Medical University of Warsaw · Tests: Tumor Tissue Collection and NGS, Blood Collection for Plasma ctDNA, ctDNA Mutation Analysis via ddPCR Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy NCT05962502Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cetuximab and irinotecan Fruquintinib in Patients With Metastatic Colorectal Cancer NCT06787105n/a42 sites📍 Biberach📍 Freiburg im Breisgau📍 Heidelberg iOMEDICO AG Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer. NCT07407465Phase 228 sites📍 Lyon📍 Marseille📍 Paris Gruppo Oncologico del Nord-Ovest · Tests: Trastuzumab-Deruxtecan (T-DXd), Capecitabine, Bevacizumab Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer NCT07228832Phase 3236 sites📍 Mobile📍 Tuscaloosa📍 Goodyear Summit Therapeutics · Tests: Drug: Ivonescimab Injection, Drug: Bevacizumab Injection Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET) NCT07283575n/a1 site📍 Shanghai Fudan University · Tests: Plasma ctDNA methylation profiling A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) NCT06749015n/a1 site📍 Shanghai Fudan University · Tests: Non interventional study Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC NCT07085169Phase 22 sites📍 Sanming📍 Shanghai Ruijin Hospital · Tests: Trifluridine/tipiracil (TAS-102) plus bevacizumab Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma NCT07463599Phase 1, Phase 21 site📍 Scottsdale HonorHealth Research Institute · Tests: Tegavivint Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes NCT06949982Phase 21 site📍 Saint Petersburg Sergey Orlov, MD · Tests: experimental group x-MAP, Regorafenib (BAY 73-4506) A Study of Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland NCT07623174n/a10 sites📍 Poznan📍 Bydgoszcz📍 Krakow Takeda · Tests: No intervention ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer NCT06825624Phase 11 site📍 Hangzhou Hansoh BioMedical R&D Company · Tests: HS-20093, Bevacizumab, 5-FU, Leucovorin, Capecitabine FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer NCT07446322Phase 219 sites📍 Homewood📍 Beverly Hills📍 Encino Oncolytics Biotech · Tests: Bevacizumab, FOLFIRI, Pelareorep A Comparative Study of Pharmacokinetics, Safety, and Immunogenicity of RPH-030 and Vectibix® in Patients With Metastatic Colorectal Cancer With Wild-type RAS as First-line Therapy in Combination With FOLFIRI NCT07543744Phase 126 sites📍 Arkhangelsk📍 Istra📍 Ivanovo R-Pharm · Tests: RPH-030, Vectibix®, Irinotecan, Calcium Folinate, Fluorouracil PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma NCT05286814Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Dexamethasone, PDS01ADC, Intera 3000 Hepatic Artery Infusion Pump (HAIP), Floxuridine ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC NCT06321081Phase 21 site📍 Beijing Beijing Hospital · Tests: irinotecan, cetuximab, envafolimab A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC) NCT04547166Phase 2, Phase 35 sites📍 Guangzhou📍 Hangzhou📍 Linyi Shanghai Henlius Biotech · Tests: HLX10, HLX04、 Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort (the REalCHALLENGE Study) NCT07536113n/a1 site📍 Milan Niguarda Hospital Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy NCT06826092Phase 21 site📍 Kaohsiung City Kaohsiung Medical University Chung-Ho Memorial Hospital · Tests: Metformin Pill, FOLFIRI plus target therapy only
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy